Mayo Clinic School of Continuous Professional Development D I S C O N T I N U E D D I S C O N T I N U E D D I Mayo Clinic 4th AnnuSal C GASTROENTEROOLOGY N T I & HEPATOLOGY UPDATE: N U E Debates On Current Controversies D D I S C O N T I ASHTON B. TAYLOR AUDITORIUM N U SCOTTSDALE, ARIZONA 5 E AMA PRA SEPTEMBER 29, 2018 D CATEGORY 1 CREDITS™ CE.MAYO.EDU/GIHEPUPDATE2018 $25 Discount when you register by August 29, 2018 COURSE DESCRIPTION This course will provide the latest, state-of-the-art information on the diagnosis and management of common disorders such as esophageal cancer; eosinophilic esophagitis; anti-coagulation; obesity – medical and endoscopic options; acute pancreatitis; hereditary aspects of gastrointestinal cancer; managing complications of cirrhosis and portal hypertension; update on cholestatic and autoimmune liver disorders; hepatitis B and C - current therapies; and controversies in liver transplantation. COURSE HIGHLIGHTS • Case-based presentations • Optional walking tour of Mayo Clinic School of Medicine • Interactive Q & A sessions EXHIBITS This course offers the unique opportunity for commercial companies to interact with healthcare providers and highlight their products and services. If you are interested in exhibiting at this course, please submit exhibitor documents to our exhibits coordinator Kristy Badder. LEARNING OBJECTIVES Upon conclusion of this course, participants should be able to: Gastroenterology objectives: • Describe and compare current endoscopic and surgical management of early esophageal cancer • Explain innovative endoscopic techniques and medical options for the treatment of obesity • Evaluate current views on the pathogenesis of acute pancreatitis • Describe the implications, and the management of eosinophilic esophagitis • Explain practical implications of prescribed and OTC anti-coagulation- related substances • Describe the latest, state-of-the-art experts’ thinking on the hereditary aspects of gastrointestinal malignancies Hepatology objectives: • Review the management of complications stemming from cirrhosis and portal hypertension • Appraise current and emerging care paradigms for autoimmune, and cholestatic liver disease • Define the latest hepatitis B and C treatment guidelines • Evaluate alcoholic hepatitis treatment and assess controversies in the use of liver transplantation for alcoholic hepatitis INTENDED AUDIENCE This course is designed for gastroenterologists, primary care physicians, and advanced healthcare practitioners. COURSE DIRECTORS Cuong C. Nguyen, M.D. Thomas J. Byrne, M.D. MEETING LOCATION Ashton B. Taylor Auditorium - Scottsdale campus 13400 East Shea Boulevard | Scottsdale, AZ 85259 ACCOMODATIONS Courtyard Scottsdale at Mayo Clinic | (800) 309-8287 13444 East Shea Boulevard | Scottsdale, Arizona 85259 Hotel rooms near the Clinic are limited. You are urged to make reservations early, as rooms are available on a first-come, first-served basis. Course rooms are $109 per night, plus applicable taxes, for single or double occupancy. Attendees are responsible for their own reservations. Standard hotel reservation confirmation and cancellation policies apply to individual reservations unless otherwise specified. Reserve your room before August 28, 2018 in order to receive a discounted rate (limited number available). Please identify yourself as a participant of the GI-Hepatology Update when making your reservation. OPTIONAL Walking Tour of the Mayo Clinic School of Medicine during lunch Mayo Clinic School of Medicine’s integration with Mayo Clinic’s world-renowned group medical practice enables students to work in the most current and comprehensive scientific disciplines and technologies, including genomics, individualized medicine, regenerative medicine, bioinformatics and more. (Space is limited – sign-up when you register for the course.) REGISTRATION CE.MAYO.EDU/GIHEPUPDATE2018 On or Before After Registration Fees (in USD) August 29, 2018 August 29, 2018 Physicians/Scientists $170 $195 Residents, Physician Assistants $125 $150 and Nurse Practitioners Visit the course website for more information on registering and our cancellation policy. MAYO CLINIC FACULTY Neena S. Abraham, M.D. Jennifer L. Horsley-Silva, M.D. Bashar A. Aqel, M.D. Cuong C. Nguyen, M.D.* Staci E. Beamer, M.D. Rahul Pannala, M.D. Thomas J. Byrne, M.D.* Lori R. Roust, M.D. Elizabeth J. Carey, M.D. Niloy Jewel Samadder, M.D. David M. Chascsa, M.D. Vijay Singh, M.B.B.S. Rolland C. Dickson, M.D. Sarah B. Umar, M.D. David E. Fleischer, M.D. *Course Directors CREDIT (JOINTLY-PROVIDED) In support of improving patient care, this activity is planned and implemented by Mayo Clinic College of Medicine and Science. Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. AMA Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation. AAFP Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending. AANP This education activity will be submitted to the American Association of Nurse Practitioners for approval of up to 5.0 contact hours of accredited education. AAPA This program is not yet approved for CME credit. Conference organizers plan to request 5.0 AAPA Category 1 CME credits from the AAPA Review Panel. The total number of approved credits is yet to be determined. AOA This program has been accredited by the American Osteopathic Association for 5.0 credits of AOA Category 2-A. ANCC Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 5.0 ANCC nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity. MOC Statement Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.0 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Other Healthcare Professionals A certificate of attendance will be provided to other healthcare professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations. SATURDAY, SEPTEMBER 29, 2018 7:00 a.m. Registration and Continental Breakfast Moderators: Cuong C. Nguyen, M.D.; Thomas J. Byrne, M.D. 7:45 Welcome Cuong C. Nguyen, M.D. SESSION I 8:00 Early Esophageal Cancer – Light or Knife? David E. Fleischer, M.D. 8:20 Early Esophageal Cancer – Knife or Light? Staci E. Beamer, M.D. 8:40 Eosinophilic Esophagitis: What’s New in 2018? Jennifer L. Horsley-Silva, M.D. 9:00 Anti-Coagulation: An Update for Gastroenterologists Neena S. Abraham, M.D. 9:20 Q & A – Panel Discussion Moderator: Cuong C. Nguyen, M.D. Panel Members: Drs. Abraham, Beamer, Fleischer and Horsley-Silva 9:40 Refreshment Break SESSION II 10:05 Obesity: Medical Options Lori R. Roust, M.D. 10:25 Obesity: Endoscopic Options Rahul Pannala, M.D. 10:45 Acute Pancreatitis: A New Paradigm Vijay Singh, M.B.B.S. 11:05 Hereditary Aspects in Gastrointestinal Cancer Niloy Jewel Samadder, M.D. 11:25 Q & A – Panel Discussion Moderator: Sarah B. Umar, M.D. Panel Members: Drs. Pannala, Roust, Samadder and Singh 11:45 Lunch–Optional Walking Tour of the Mayo Clinic School of Medicine SESSION III 12:45 p.m. Management of the Complications of Cirrhosis and Portal Hypertension David M. Chascsa, M.D. 1:05 Update on Cholestatic and Autoimmune Liver Conditions Elizabeth J. Carey, M.D. 1:25 Hepatitis B and C in 2018: Current Therapy Bashar A. Aqel, M.D. 1:45 Controversies in Liver Transplantation: Alcoholic Hepatitis Rolland C. Dickson, M.D. 2:05 Q & A – Panel Discussion Moderator: Thomas J. Byrne, M.D. Panel Members: Drs. Aqel, Carey, Chascsa and Dickson 2:25 Meeting Adjourn Program is subject to change without notice. 8 1 0 2 9, 2 st u g u A y b r e st MAYO CLINIC 13400 East Shea Boulevard Scottsdale, Arizona 85259 ce.mayo.eduWebsite: [email protected]: (480) 301-4580Phone: when you regi$25 Discount Y:s E e GTsi Ar O e Dv L o OPtr 0518 n v U e R o 53r C 00- 3 Y 8 lE C a M Mayo Clinic 4th AnnuGASTROENT& HEPATOLOGDebates On Current SHTON B. TAYLOR AUDITORIUMCOTTSDALE, ARIZONA EPTEMBER 29, 2018 CE.MAYO.EDU/GIHEPUPDATE2018 hone registrations not accepted—online only) 018 Mayo Foundation for Medical Education and Research | AS S (P ©2
Description: